Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug ...
Stocktwits on MSN
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug?
The selloff comes as blarcamesine completed its oral explanation during the EMA’s Nov. 10–13 review window. ・The therapy reached this stage after progressing through the Day-120 and Day-180 questions ...
Stocktwits on MSN
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug
Shares of Anavex Life Sciences (AVXL) slumped 8% in the premarket session on Friday after a European Medicines Agency (EMA) ...
AMD stock surged 11% after CEO Lisa Su outlined bold growth targets, forecasting a 35% annual revenue increase and $20 EPS — ...
The trends on Gift Nifty also indicate a flat-to-positive start for the Indian benchmark index. The Gift Nifty was trading ...
Emera Inc. closed 3.4% below its 52-week high of C$69.62, which the company reached on October 22nd.
Shares of Emera Inc. EMA dropped 0.22% to C$67.08 Monday, in what proved to be an otherwise all-around positive trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback